10-K Decoder · All companies

REGENXBIO Inc.

RGNX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$170M$83.3M+105%
Operating income−$161M−$233M+30.9%
Net income−$194M−$227M+14.6%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$9.20M$29.7M−69.0%
Operating income−$35.5M−$52.4M+32.3%
Net income−$40.7M−$61.9M+34.2%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was REGENXBIO's revenue in FY2025?
$170M in FY2025 (Fiscal year ended Dec 31, 2025), +105% vs $83.3M a year earlier, per its 10-K filed Mar 2026.
Was REGENXBIO profitable in FY2025?
No: net income was −$194M and operating income −$161M in FY2025.
What was REGENXBIO's revenue in Q3 2026?
$9.20M (−69.0% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.